🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

*Over 2 decades, PSM rates have dropped, with robot use reducing PSM in OPC. This study explores PSM trends & predictors in OPSCC & OCSCC using the NCDB. #CancerResearch #Oncology Rahul K. Sharma, MD Ryan Orosco Ramez Philips, MD Farhoud Faraji Antoinette Esce, MD Michael Topf MD, MSCI …-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/oh…

Dr. Connie Ma PGY-4 resident VUMC Otolaryngology–Head and Neck Surgery presenting on early division of paramedian forehead flaps at the The Triological Society meeting #orlando

Very proud of Whitney Jin and Sindhura Sridhar who both gave excellent podium presentations at the The Triological Society Combined Sections Meeting #headandneck #orlando VUMC Otolaryngology–Head and Neck Surgery Eben L Rosenthal, MD Alexander Langerman (he/him) 🏳‍🌈🇺🇦🇺🇸

*Incorporating 3D visual #Pathology reports for H&N cancer improves communication and reduces report length. Each report integrates 3D scans, tumor details, & diagnoses in a single page. Carly Fassler Marina Aweeda Alexander Langerman (he/him) 🏳‍🌈🇺🇦🇺🇸 Eben L Rosenthal, MD Michael Topf MD, MSCI sciencedirect.com/science/articl…

Looking forward to presenting at #vMed25 #AugmentedReality #surgicaloncology @VUMC_Cancer VUMC Otolaryngology–Head and Neck Surgery

Sooooo thrilled to be a Buckeye !!!! ❤️🌰

I am so excited to have matched into Otolaryngology-Head and Neck Surgery Jefferson Otolaryngology- Head and Neck Surgery ✨ I’m overcome with gratitude - thank you to my village of mentors, friends, and incredible family who believed in me every step of the way. #IAMOTO #OtoMatch2025 AmAcadOtolaryngology The Triological Society

Enjoyed presenting at #vMed25 on our teams visual pathology report and augmented reality protocols. Cedars-Sinai American Medical Extended Reality Association Very engaging meeting with wonderful insight from #extendedreality thought leaders Sindhura Sridhar VUMC Otolaryngology–Head and Neck Surgery @VUMC_Cancer

“It’s really exciting. It’s a new frontier for our patients.” Ravi Uppaluri, MDPhD of Dana-Farber discussed data from KEYNOTE-689 trial that showed KEYTRUDA (pembrolizumab) significantly extended EFS for patients with advanced HNSCC. AACR Brigham and Women's Hospital Harvard Medical School bit.ly/3YPEsdE

Had a great time at my first COSM meeting! #COSM2025 Thank you to AHNS The Triological Society for the opportunity to present our research, and honored to receive recognition for our study investigating treatment priorities in patients with laryngeal cancer. VUMC Otolaryngology–Head and Neck Surgery Michael Topf MD, MSCI

Marina Aweeda VUMC Otolaryngology–Head and Neck Surgery Michael Topf MD, MSCI Carly Fassler Had to continue the trend! We’re lucky to work with such phenomenal mentors- can’t wait for you both to join in Nashville! Andreja Radevic @JAusterlitz27

Thank you COSM and my mentor Michael Topf MD, MSCI for the opportunity to present my research, connect with leaders in the field, and explore the beautiful city of New Orleans! VUMC Otolaryngology–Head and Neck Surgery AHNS

Work 💪🏻to be done to prove the potential value of #neoadjuvant #C-PRE NRG Oncology #HN014 Time to enroll! NCI Cancer Control CCTG Trans Tasman Radiation Oncology Group

Pembrolizumab now FDA Oncology approved in resectable LA-HNSCC based off KEYNOTE-689: - mEFS: 51.8 vs 30.4 most (HR: 0.73) - Benefit greater with CPS ≥10 (HR 0.66) - 2yr EFS: 75% vs 62% #OncTwitter #MedTwitter OncoAlert #ASCO25 #AACR25

FDA approves pembrolizumab for resectable, locally advanced HNSCC based on KEYNOTE‑689. Led by Dr. Ravindra Uppaluri Ravi Uppaluri, MDPhD, the study showed a 30% drop in recurrence risk. Full details from The ASCO Post: ascopost.com/news/june-2025… #HNSCC #Oncology

Dr. Annie Moroco (Annie Moroco, MD) was presented with the Ellie Goldenberg (z"l) Award at the PAO-HNS Annual Meeting. This meaningful award, established by Drs. Renee and David Goldenberg, recognizes individuals who embody Ellie’s spirit of hard work, dedication, and kindness.

Original Article: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer (KEYNOTE-689 phase 3 trial) nej.md/45X0Nuc Editorial: Harnessing Immunotherapy in Curative-Intent Treatment of Head and Neck Cancer nej.md/4e6T0fr #Oncology

The technology for fluroescence guided surgery keeps improving. nature.com/collections/ec… #SurgOnc #VUMC VUMC Otolaryngology–Head and Neck Surgery Stanford Otolaryngology - Head & Neck Surgery

Enjoying Liverpool and the International Academy of Oral Oncology meeting. Wonderful city and discussion on advancements in oral cancer. VUMC Otolaryngology–Head and Neck Surgery

Thank you to everyone who joined us for this year's Surgeon Scientists in Otolaryngology Symposium (S30)! Your engagement and insights sparked a dynamic exchange between novice and experienced clinician-investigators across the nation. #Innovation #ENT #VUMC #ResearchExcellence